Invesco provides investment-management services to retail (70% of managed assets) and institutional (30%) clients... Show more
Invesco Ltd. manages approximately $2.16 trillion in AUM as of March 2026, with a diversified portfolio spanning equities, fixed income, alternatives, and multi-asset solutions. The firm holds a competitive edge as a top-5 U.S. ETF provider, home to popular products tracking benchmarks like the Nasdaq-100. Its push into active ETFs differentiates it from pure passive giants such as Vanguard and BlackRock, blending systematic approaches with institutional-grade strategies. Medium-term positioning benefits from global scale, innovation in enhanced equity products, and a focus on high-margin areas like private credit and real assets. However, structural challenges include fee pressure from passive flows and competition in core active management, prompting ongoing portfolio optimization through divestitures.
The Q1 2026 earnings release on April 28 represents the nearest catalyst, with consensus estimates calling for EPS of $0.60 and revenue of $1.27 billion. Investors will scrutinize AUM updates, net flows—particularly in ETFs—and guidance on full-year profitability, as beats could spur analyst upgrades. Recent strategic moves, including the sale of Canadian retail assets to CI Global Asset Management, signal a refocus on core strengths and could unlock capital for buybacks or growth initiatives. Analyst sentiment shows mixed revisions: Argus raised its target to $31 (Buy) in January, while JPMorgan cut to $25; overall, 15-20 analysts maintain a Hold/Buy stance with targets averaging $26-27. Further M&A, regulatory shifts in asset management, or ETF product launches could also sway sentiment.
The asset management sector anticipates robust ETF growth in 2026, with institutional holdings posting a 14.4% five-year CAGR through 2025, extending into higher allocations for liquidity and efficiency. Invesco's business model is highly sensitive to equity and bond market returns, which directly impact AUM valuation, alongside organic flows. Expected U.S. interest rate cuts should encourage risk-on positioning, boosting demand for growth-oriented ETFs, though elevated rates have supported money market fund inflows. Broader forces include persistent inflation moderation, geopolitical tensions affecting global allocations, and regulatory focus on fee transparency, all tying into Invesco's fee-based revenue structure.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality for timely insights. Traders can leverage this engine to enhance decision-making in dynamic markets.
Analysts project 2026 earnings of $2.63 per share, a 29.6% increase, driven by AUM expansion toward $2.2 trillion-plus and operational efficiencies. Long-term themes include ETF market share gains amid passive dominance, cost discipline from divestitures, and margin expansion in alternatives. Technology adoption for active strategies and potential regulatory easing could support growth, while competitive threats from low-fee providers loom. Consensus expectations of 8%+ annual earnings growth underscore optimism around capital returns and market tailwinds, though sustained equity rallies remain pivotal.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a provider of investment management services
Industry InvestmentManagers
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with PFG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then PFG could also see price increases.
The Stochastic Oscillator for IVZ moved into oversold territory on June 24, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .
IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 234 cases where IVZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on June 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for IVZ turned negative on June 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
IVZ moved below its 50-day moving average on June 24, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.309) is normal, around the industry mean (4.328). P/E Ratio (19.476) is within average values for comparable stocks, (25.636). Projected Growth (PEG Ratio) (0.929) is also within normal values, averaging (1.361). Dividend Yield (0.029) settles around the average of (0.094) among similar stocks. P/S Ratio (1.986) is also within normal values, averaging (17.341).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.